Tocvan Ventures Corp Stock Net Income
| TCVNF Stock | USD 0.76 0.08 11.76% |
Fundamental analysis of Tocvan Ventures allows traders to better anticipate movements in Tocvan Ventures' stock price by examining its financial health and performance throughout various phases of its business cycle.
Tocvan |
Tocvan Ventures Corp OTC Stock Net Income Analysis
Tocvan Ventures' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Tocvan Ventures Net Income | (2.2 M) |
Most of Tocvan Ventures' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tocvan Ventures Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Tocvan Ventures Corp reported net income of (2.2 Million). This is 81.73% lower than that of the Basic Materials sector and significantly lower than that of the Other Industrial Metals & Mining industry. The net income for all United States stocks is 100.39% higher than that of the company.
Tocvan Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tocvan Ventures' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tocvan Ventures could also be used in its relative valuation, which is a method of valuing Tocvan Ventures by comparing valuation metrics of similar companies.Tocvan Ventures is currently under evaluation in net income category among its peers.
Tocvan Fundamentals
| Return On Equity | -0.53 | |||
| Return On Asset | -0.16 | |||
| Current Valuation | 12.51 M | |||
| Shares Outstanding | 38.29 M | |||
| Shares Owned By Insiders | 4.86 % | |||
| Price To Book | 4.02 X | |||
| EBITDA | (2.19 M) | |||
| Net Income | (2.2 M) | |||
| Cash And Equivalents | 396.16 K | |||
| Cash Per Share | 0.01 X | |||
| Current Ratio | 2.68 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (912.84 K) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 0.48 | |||
| Market Capitalization | 16.62 M | |||
| Total Asset | 7.64 M | |||
| Net Asset | 7.64 M |
About Tocvan Ventures Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tocvan Ventures Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tocvan Ventures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tocvan Ventures Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Tocvan OTC Stock
Tocvan Ventures financial ratios help investors to determine whether Tocvan OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tocvan with respect to the benefits of owning Tocvan Ventures security.